Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Applied Research and Development Grants - Level 1

Algonquin College of Applied Arts and Technology

$25,000.00

Portable chemiluminescence reader for highly sensitive detection of viral antigens

FY 2013-14

Summary
EVIK Diagnostic Innovations Inc. (EDI) develops Immunoassay-on-a-Chip device for rapid identification of clinically significant bacterial and viral antigens. EDI's immunoassay technology is based on a highly sensitive detection of chemiluminescent light emitted by reacting chemical agents. This novel technology offers a huge potential for early diagnosis of widely spread health problems. The main focus of the proposed project will be on developing a new method for chemiluminescent opticalsignal acquisition and digital image processing in order to improve the immunoassay device sensitivity. The new concepts will be proven by building a prototype of a Portable Reader-Analyzer. This optoelectronic module will be tasked with acquiring digital images of the reagent zone in chemiluminescent light and analyzing them with customized image processing software. These studies will accelerate the process of commercializing a new generation of Immunoassay-on-a-Chipdevices. As a result, the industrial partner, EDI, will strengthen its position and will expand its share in the dynamic medical diagnostic test devices market.
Program
Applied Research and Development Grants - Level 1
Location
Ontario, Canada
Recipient Type
Other
Type
Grant
Source
NSERC's Awards Data

As published

Application id
446431-2012
Name nom
BrundelRe, Riccardo
Department département
Head Office
Organization id
2324
Institution établissement
Algonquin College of Applied Arts and Technology
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2012
Award amount
25000
Program id
CARD1
Program name en
Applied Research and Development Grants - Level 1
Program name fr
Subventions de recherche et développement appliquée - niveau 1
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1561
Committee name en
Applied Research and Development Grants
Committee name fr
Subventions de recherche et développement appliquée
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
1
Application title
Portable chemiluminescence reader for highly sensitive detection of viral antigens
Keyword
NSERC
Application summary
EVIK Diagnostic Innovations Inc. (EDI) develops Immunoassay-on-a-Chip device for rapid identification of clinically significant bacterial and viral antigens. EDI's immunoassay technology is based on a highly sensitive detection of chemiluminescent light emitted by reacting chemical agents. This novel technology offers a huge potential for early diagnosis of widely spread health problems. The main focus of the proposed project will be on developing a new method for chemiluminescent opticalsignal acquisition and digital image processing in order to improve the immunoassay device sensitivity. The new concepts will be proven by building a prototype of a Portable Reader-Analyzer. This optoelectronic module will be tasked with acquiring digital images of the reagent zone in chemiluminescent light and analyzing them with customized image processing software. These studies will accelerate the process of commercializing a new generation of Immunoassay-on-a-Chipdevices. As a result, the industrial partner, EDI, will strengthen its position and will expand its share in the dynamic medical diagnostic test devices market.
Algonquin College of Applied Arts and Technology - $2… | Canada Spends